We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$66.4B
AUM Growth
+$5.93B
(+9.8%)
Cap. Flow
-$619M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
13.02%
Holding
3,510
New
779
Increased
864
Reduced
1,015
Closed
774
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown & Brown
BRO
|
+$500M |
| 2 |
Arista Networks
ANET
|
+$316M |
| 3 |
Union Pacific
UNP
|
+$271M |
| 4 |
Eli Lilly
LLY
|
+$271M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$495M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$388M |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 4 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$369M |
| 5 |
Mastercard
MA
|
+$342M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.78% |
| 2 | Consumer Discretionary | 9.99% |
| 3 | Financials | 9.73% |
| 4 | Industrials | 7.81% |
| 5 | Healthcare | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
1201
DELISTED
Cidara Therapeutics
CDTX
| $5.71M | 0.01% |
+117,199
| New | +$2.82M |
|
1202
PUT
DraftKings
DKNG
$12.6B
| $5.7M | 0.01% |
132,900
-193,700
| -59% | -$6.95M |
|
1203
CALL
Sea Limited
SE
$80.5B
| $5.69M | 0.01% |
45,400
+16,400
| +57% | +$2.37M |
|
1204
PUT
UnitedHealth
UNH
$365B
| $5.68M | 0.01% |
18,200
-55,300
| -75% | -$21.1M |
|
1205
PUT
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $5.66M | 0.01% |
10,000
| – | – |
|
1206
Dorian LPG
LPG
$1.84B
| $5.66M | 0.01% |
232,293
+57,804
| +33% | +$1.28M |
|
1207
PUT
EQT Corp
EQT
$34B
| $5.63M | 0.01% |
96,600
-81,300
| -46% | -$4.39M |
|
1208
Talkspace
TALK
$869M
| $5.62M | 0.01% |
2,021,738
+603,252
| +43% | +$1.78M |
|
1209
Liberty Global Class A
LBTYA
$3.48B
| $5.61M | 0.01% |
560,261
+428,034
| +324% | +$4.3M |
|
1210
PUT
AbbVie
ABBV
$442B
| $5.61M | 0.01% |
30,200
-90,900
| -75% | -$16.9M |
|
1211
Construction Partners
ROAD
$6.86B
| $5.6M | 0.01% |
52,727
+5,621
| +12% | +$525K |
|
1212
Tarsus Pharmaceuticals
TARS
$3.05B
| $5.59M | 0.01% |
138,019
+78,345
| +131% | +$3.53M |
|
1213
Tyra Biosciences
TYRA
$1.5B
| $5.58M | 0.01% |
583,386
+340,142
| +140% | +$3.23M |
|
1214
Cognex
CGNX
$10.6B
| $5.58M | 0.01% |
175,969
+27,761
| +19% | +$795K |
|
1215
Griffon
GFF
$4.84B
| $5.57M | 0.01% |
76,908
-40,412
| -34% | -$2.81M |
|
1216
Huntsman Corp
HUN
$1.83B
| $5.57M | 0.01% |
+534,115
| New | +$6.51M |
|
1217
Claros Mortgage Trust
CMTG
$261M
| $5.55M | 0.01% |
1,946,597
+362,130
| +23% | +$971K |
|
1218
Bunge Global
BG
$21.4B
| $5.51M | 0.01% |
+68,695
| New | +$5.41M |
|
1219
CALL
Dollar General
DG
$26.5B
| $5.51M | 0.01% |
48,200
-99,800
| -67% | -$9.91M |
|
1220
Innoviva
INVA
$1.5B
| $5.5M | 0.01% |
273,617
-29,670
| -10% | -$571K |
|
1221
Johnson & Johnson
JNJ
$626B
| $5.49M | 0.01% |
35,951
-349,708
| -91% | -$53.8M |
|
1222
PUT
Wynn Resorts
WYNN
$10.8B
| $5.48M | 0.01% |
58,500
+28,900
| +98% | +$2.45M |
|
1223
U-Haul Holding Co Series N
UHAL.B
$12.5B
| $5.47M | 0.01% |
+100,594
| New | +$5.61M |
|
1224
PUT
TKO Group
TKO
$14.2B
| $5.46M | 0.01% |
+30,000
| New | +$4.82M |
|
1225
GE Vernova
GEV
$269B
| $5.45M | 0.01% |
10,308
-19,582
| -66% | -$8.15M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2025 Portfolio in Review
As of Q2 2025, Balyasny Asset Management held 3,510 positions worth $66.4B, up 9.8% from $60.5B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Balyasny Asset Management's Q2 2025 filing shows 779 new, 864 increased, 1,015 reduced and 774 closed positions. Its largest new stake was Arista Networks: 3,646,977 shares worth $373M. The largest sale was iShares Core S&P 500 ETF, an estimated $495M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Financials.
- Balyasny Asset Management's largest Q2 2025 buy was Arista Networks: 3,646,977 shares worth $373M.
- Balyasny Asset Management added most to Brown & Brown in Q2 2025, an estimated $500M increase.
- Balyasny Asset Management's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $495M.
- Balyasny Asset Management fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2025, selling an estimated $369M.
- Balyasny Asset Management's ten largest holdings make up 13% of its $66.4B portfolio in Q2 2025.
- Balyasny Asset Management opened 779 new positions and closed 774 in Q2 2025.
- Balyasny Asset Management's portfolio value rose 9.8% quarter-over-quarter to $66.4B.
Based on Balyasny Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.